Technivie, a hepatitis C treatment drug made by AbbVie, has been linked to side effects including severe liver disease which may require a liver transplant or even lead to death.
Free Confidential Lawsuit Evaluation: If you had liver failure or required a liver transplant, or someone you know died from liver disease after taking Technivie, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.
What’s the Problem?
Manufactured by AbbVie, Technivie is used to treat genotype 1 chronic hepatitis C in adults, including patients with compensated cirrhosis. The U.S. Food & Drug Administration (FDA) allegedly based Technivie’s initial approval on incomplete studies which found a 90% hepatitis C cure rate in patients who took the medication.
However, less than 6 months after Technivie entered the U.S. market, FDA issued a warning about the drug’s link to severe liver injuries.
Hep C Treatment Linked to Liver Disease
FDA in December 2015 announced a label change for Technivie and Viekira Pak (another hepatitis C treatment manufactured by AbbVie), indicating that the drugs could cause serious liver injury in patients with underlying liver disease. A review of the FDA Adverse Event Reporting System (FAERS) found at least 26 cases of “hepatic decompensation” and liver failure — some of which resulted in the need for a liver transplant or even death — in hepatitis C patients treated with Technivie or Viekira Pak. Most of these injuries occurred within 1 to 4 weeks of patients initiating treatment with the drugs.
Liver Failure Symptoms
Early symptoms of liver failure include:
- Loss of appetite
As the disease becomes more advanced, symptoms are more serious:
- Bleeding easily
- Swollen abdomen
- Mental disorientation or confusion (hepatic encephalopathy)
Complications of Cirrhosis
Cirrhosis is long-term (chronic) liver disease, and occurs when scar tissue replaces healthy liver tissue which stops the liver from working properly. Unfortunately, no treatment will cure cirrhosis or repair scarring in the liver that has already occurred. Treatment typically includes a combination of lifestyle changes, medications and regular doctor visits.
If left untreated, complications of cirrhosis may include edema and ascites, spontaneous bacterial peritonitis, bleeding from varices, hepatic encephalopathy, hepatorenal syndrome, hepatopulmonary syndrome, hypersplenism, and liver cancer.
Has a Class Action Been Filed?
Technivie has only been on the U.S. market a short time, and no class action lawsuit has been filed over side effects alleged from the drug. But that doesn’t mean you’re out of luck if you’ve been injured. Our lawyers are now accepting potential individual claims on behalf of people who took Technivie for genotype 1 chronic hepatitis C infection (including those with compensated cirrhosis) and subsequently developed liver failure, required a liver transplant, or died from liver disease. Serious liver injury must have occurred within 1 to 4 weeks of initiating treatment with Technivie.
Do I Have a Technivie Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Technivie lawsuits. We are handling individual litigation nationwide and currently accepting new liver damage cases in all 50 states.
Free Case Evaluation: Again, if you had liver failure or required a liver transplant, or someone you know died from liver disease after taking Technivie, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.